BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 38543274)

  • 1. The Role of Heat Shock Proteins in Cisplatin Resistance.
    Krawczyk Z; Gogler-Pigłowska A; Sojka DR; Scieglinska D
    Anticancer Agents Med Chem; 2018; 18(15):2093-2109. PubMed ID: 30156165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-κB pathway.
    Yu M; Qi B; Xiaoxiang W; Xu J; Liu X
    Biomed Pharmacother; 2017 Jun; 90():677-685. PubMed ID: 28415048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of Heat Shock Protein Expression in Alveolar Adenocarcinoma Cells through Gold Nanoparticles and Cisplatin Treatment.
    Ibrahim B; Akere TH; Chakraborty S; Valsami-Jones E; Ali-Boucetta H
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling.
    Wang LH; Li Y; Yang SN; Wang FY; Hou Y; Cui W; Chen K; Cao Q; Wang S; Zhang TY; Wang ZZ; Xiao W; Yang JY; Wu CF
    Br J Cancer; 2014 Jan; 110(2):341-52. PubMed ID: 24300974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Wogonoside reverses cisplatin resistance in SGC7901/cDDP cells through inhibition of PI3K/Akt/Nrf2/ARE signaling pathway].
    Wang LJ; Wang SG; Deng TX
    Sheng Li Xue Bao; 2018 Aug; 70(4):397-405. PubMed ID: 30112565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RNA Interference targeting GRP75 decreases cisplatin resistance in human lung adenocarcinoma cell].
    Shi S; He Z; Cai J; Qiu J
    Zhongguo Fei Ai Za Zhi; 2011 Apr; 14(4):305-10. PubMed ID: 21496427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Gold Nanoparticles Suppress the Proliferation of Human Lung Alveolar Adenocarcinoma Cells by Deubiquitinating Enzymes Inhibition.
    Ibrahim B; Akere TH; Chakraborty S; Valsami-Jones E; Ali-Boucetta H
    ACS Omega; 2023 Oct; 8(43):40622-40638. PubMed ID: 37929120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gold nanoparticles and gold nanorods in the landscape of cancer therapy.
    Kesharwani P; Ma R; Sang L; Fatima M; Sheikh A; Abourehab MAS; Gupta N; Chen ZS; Zhou Y
    Mol Cancer; 2023 Jun; 22(1):98. PubMed ID: 37344887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selamectin increases cisplatin sensitivity by inhibiting cisplatin-resistant genes expression and autophagy in uveal melanoma.
    He J; Chen J; Shen J
    Biochem Biophys Res Commun; 2023 Jun; 661():75-81. PubMed ID: 37087801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gold Nanoparticles Induced Size Dependent Cytotoxicity on Human Alveolar Adenocarcinoma Cells by Inhibiting the Ubiquitin Proteasome System.
    Ibrahim B; Akere TH; Chakraborty S; Valsami-Jones E; Ali-Boucetta H
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of reactive oxygen species, mitochondrial membrane potential, and p53 in evodiamine-induced apoptosis and G2/M arrest of human anaplastic thyroid carcinoma cells.
    Chien CC; Wu MS; Chou SW; Jargalsaikhan G; Chen YC
    Chin Med; 2021 Dec; 16(1):134. PubMed ID: 34886886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of silver nanoparticles and cisplatin in combating inflammation and hyperplasia of airway stents.
    Li Z; Tian C; Jiao D; Li J; Li Y; Zhou X; Zhao H; Zhao Y; Han X
    Bioact Mater; 2022 Mar; 9():266-280. PubMed ID: 34820570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pathogenic Role of PI3K/AKT Pathway in Cancer Onset and Drug Resistance: An Updated Review.
    Rascio F; Spadaccino F; Rocchetti MT; Castellano G; Stallone G; Netti GS; Ranieri E
    Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439105
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.